NCT06747208

Brief Summary

This study focuses on swallowing dysfunction, a common issue affecting 60-75% of head and neck cancer patients due to tumor damage, treatment complications, and chemoradiotherapy side effects, which can lead to malnutrition and reduced quality of life. With limited research on the effects of radiation doses on swallowing muscles and nutrition, this study aims to evaluate these impacts in non-surgical patients undergoing radiotherapy, conducting assessments before treatment, three months after, and within one year post-treatment.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
69mo left

Started Jan 2025

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Jan 2025Dec 2031

First Submitted

Initial submission to the registry

December 15, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 24, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2031

Last Updated

December 24, 2024

Status Verified

December 1, 2024

Enrollment Period

6 years

First QC Date

December 15, 2024

Last Update Submit

December 18, 2024

Conditions

Keywords

dysphagiahead and neck cancerradiation therapy

Outcome Measures

Primary Outcomes (1)

  • hypopharyngeal mean peak pressure

    hypopharyngeal contraction

    one year

Study Arms (1)

head and neck cancer patients

patients with head and neck cancer undergoing radiation therapy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with head and neck cancer undergoing radiation therapy

You may qualify if:

  • Patients scheduled to undergo radiotherapy or concurrent chemoradiotherapy ;
  • Aged between 18 and 80 years;
  • Able to perform self-care independently (ECOG ≤ 2);
  • All patients provide written informed consent.

You may not qualify if:

  • Patients scheduled to undergo surgical treatment;
  • Patients with neuromuscular diseases, such as stroke or Parkinson's disease;
  • Patients with other diseases or complications, including heart disease classified as NYHA functional class ≥ 2 with thrombotic conditions, or lung disease classified as Hugh-Jones grade ≥ 4;
  • Patients with psychological disorders that may affect their ability to provide informed consent or comply with the study protocol;
  • Patients who do not consent to undergo high-resolution impedance manometry.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

the DNA associated with nutrition

MeSH Terms

Conditions

Deglutition DisordersHead and Neck Neoplasms

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesNeoplasms by SiteNeoplasms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Anesthesiologist

Study Record Dates

First Submitted

December 15, 2024

First Posted

December 24, 2024

Study Start

January 1, 2025

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2031

Last Updated

December 24, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

due to ethical issue